Skip to main content

Advertisement

Log in

Adult keratoplasty: has the prognosis improved in the last 25 years?

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Adult keratoplasty outcomes have significantly improved in the past quarter century as a result of new pharmaceuticals, advanced surgical devices, better understanding of what causes graft failure, and targeted techniques for selective replacement of only diseased corneal layers. Prevention and treatment of graft rejection, which has long been a leading cause of graft failure, has improved with the development of innovative topical and systemic immuno-suppressants. New methods for preventing and treating ocular surface complications have been devised, and limbal stem cell grafts have significantly improved management of severe ocular surface disease. Improved intraocular lens designs cause less corneal damage and have increased corneal graft survival. Non-steroidal anti-inflammatory (NSAID) eyedrops and more complete vitrectomies have reduced the incidence of chronic cystoid macular edema, which could prevent eyes with clear grafts from regaining useful vision. Patients with keratoconus or corneal scars can now benefit from advanced anterior lamellar keratoplasty techniques, which reduce the risk of immunologic rejection and endothelial failure, while matching the visual outcomes achieved with penetrating keratoplasty. Patients with endothelial dysfunction can now benefit from advanced endothelial keratoplasty techniques, which provide more rapid visual recovery, minimize induced astigmatism and ocular surface problems, and virtually eliminate the risk of wound rupture from minor trauma. Finally, femtosecond lasers now provide transplant surgeons with a precise tool for creating complex, interlocking corneal incisions that may facilitate wound healing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bertelmann E, Reinhard T, Pleyer U (2003) [Current practice of immune prophylaxis and therapy in perforating keratoplasty. A survey of members of the Cornea Section of the German Ophthalmological Society]. Ophthalmologe 100:1031–1035

    Article  PubMed  CAS  Google Scholar 

  2. Price MO, Price FW Jr (2006) Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes. Ophthalmology 113:1785–1790

    Article  PubMed  Google Scholar 

  3. Perry HD, Donnenfeld ED, Acheampong A et al (1998) Topical Cyclosporine A in the management of postkeratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5% cyclosporine A into the cornea and anterior chamber. CLAO J 24:159–165

    PubMed  CAS  Google Scholar 

  4. Cosar CB, Laibson PR, Cohen EJ, Rapuano CJ (2003) Topical cyclosporine in pediatric keratoplasty. Eye Contact Lens 29:103–107

    Article  PubMed  Google Scholar 

  5. Belin MW, Bouchard CS, Frantz S, Chmielinska J (1989) Topical cyclosporine in high-risk corneal transplants. Ophthalmology 96:1144–1150

    PubMed  CAS  Google Scholar 

  6. Inoue K, Amano S, Kimura C et al (2000) Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty. Jpn J Ophthalmol 44:302–305

    Article  PubMed  CAS  Google Scholar 

  7. Randleman JB, Stulting RD (2006) Prevention and treatment of corneal graft rejection: current practice patterns 2004. Cornea 25:286–290

    Article  PubMed  Google Scholar 

  8. Reis A, Reinhard T, Voiculescu A et al (1999) Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial. Br J Ophthalmol 83:1268–1271

    Article  PubMed  CAS  Google Scholar 

  9. Reinhard T, Reis A, Bohringer D et al (2001) Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years’ results of a randomized prospective clinical trial. Graefes Arch Clin Exp Ophthalmol 239:367–372

    Article  PubMed  CAS  Google Scholar 

  10. Reinhard T, Mayweg S, Reis A, Sundmacher R (2005) Topical FK506 as immunoprophylaxis after allogeneic penetrating normal-risk keratoplasty: a randomized clinical pilot study. Transpl Int 18:193–177

    Article  PubMed  CAS  Google Scholar 

  11. Thompson RW Jr, Price MO, Bowers PJ, Price FW Jr (2003) Long-term graft survival after penetrating keratoplasty. Ophthalmology 110:1396–1402

    Article  PubMed  Google Scholar 

  12. Ing JJ, Ing HH, Nelson LR et al (1998) Ten-year postoperative results of penetrating keratoplasty. Ophthalmology 105:1855–1865

    Article  PubMed  CAS  Google Scholar 

  13. Boisjoly HM, Tourigny R, Bazin R et al (1993) Risk factors of corneal graft failure. Ophthalmology 100:1728–1735

    PubMed  CAS  Google Scholar 

  14. Price MO, Thompson RW Jr, Price FW Jr (2003) Risk factors for various causes of failure in initial corneal grafts. Arch Ophthalmol 121:1087–1092

    Article  PubMed  Google Scholar 

  15. Wilson SE, Kaufman HE (1990) Graft failure after penetrating keratoplasty. Surv Ophthalmol 34:325–356

    Article  PubMed  CAS  Google Scholar 

  16. Lee DA, Higginbotham EJ (2005) Glaucoma and its treatment: a review. Am J Health Syst Pharm 62:691–699

    Article  PubMed  Google Scholar 

  17. Baudouin C, Pisella PJ, Fillacier K et al (1999) Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 106:556–563

    Article  PubMed  CAS  Google Scholar 

  18. Burstein NL (1980) Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. Surv Ophthalmol 25:15–30

    Article  PubMed  CAS  Google Scholar 

  19. Beebe WE, Starita RJ, Fellman RL et al (1990) The use of Molteno implant and anterior chamber tube shunt to encircling band for the treatment of glaucoma in keratoplasty patients. Ophthalmology 97:1414–1422

    PubMed  CAS  Google Scholar 

  20. McDonnell PJ, Robin JB, Schanzlin DJ et al (1988) Molteno implant for control of glaucoma in eyes after penetrating keratoplasty. Ophthalmology 95:364–369

    PubMed  CAS  Google Scholar 

  21. Coleman AL, Mondino BJ, Wilson MR, Casey R (1997) Clinical experience with the Ahmed Glaucoma Valve implant in eyes with prior or concurrent penetrating keratoplasties. Am J Ophthalmol 123:54–61

    PubMed  CAS  Google Scholar 

  22. Kwon YH, Taylor JM, Hong S et al (2001) Long-term results of eyes with penetrating keratoplasty and glaucoma drainage tube implant. Ophthalmology 108:272–278

    Article  PubMed  CAS  Google Scholar 

  23. Brady SE, Rapuano CJ, Arentsen JJ et al (1989) Clinical indications for and procedures associated with penetrating keratoplasty, 1983–1988. Am J Ophthalmol 108:118–122

    PubMed  CAS  Google Scholar 

  24. Robin JB, Gindi JJ, Koh K et al (1986) An update of the indications for penetrating keratoplasty. 1979 through 1983. Arch Ophthalmol 104:87–89

    PubMed  CAS  Google Scholar 

  25. Smith RE, McDonald HR, Nesburn AB, Minckler DS (1980) Penetrating keratoplasty: changing indications, 1947 to 1978. Arch Ophthalmol 98:1226–1229

    PubMed  CAS  Google Scholar 

  26. Smith PW, Wong SK, Stark WJ et al (1987) Complications of semiflexible, closed-loop anterior chamber intraocular lenses. Arch Ophthalmol 105:52–57

    PubMed  CAS  Google Scholar 

  27. Price FW Jr (1988) Factors contributing to corneal decompensation with the Stableflex lens. J Cataract Refract Surg 14:53–57

    PubMed  Google Scholar 

  28. Kang PC, Klintworth GK, Kim T et al (2005) Trends in the indications for penetrating keratoplasty, 1980–2001. Cornea 24:801–803

    Article  PubMed  Google Scholar 

  29. Price FW Jr, Whitson WE (1990) Natural history of cystoid macular edema in pseudophakic bullous keratopathy. J Cataract Refract Surg 16:163–169

    PubMed  Google Scholar 

  30. Solomon KD, Cheetham JK, DeGryse R et al (2001) Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery. Ophthalmology 108:331–337

    Article  PubMed  CAS  Google Scholar 

  31. Ang LP, Tan DT (2004) Ocular surface stem cells and disease: current concepts and clinical applications. Ann Acad Med Singapore 33:576–580

    PubMed  CAS  Google Scholar 

  32. Holland EJ, Djalilian AR, Schwartz GS (2003) Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique. Ophthalmology 110:125–130

    Article  PubMed  Google Scholar 

  33. Busin M, Zambianchi L, Arffa RC (2005) Microkeratome-assisted lamellar keratoplasty for the surgical treatment of keratoconus. Ophthalmology 112:987–997

    Article  PubMed  Google Scholar 

  34. Melles GR, Remeijer L, Geerards AJ, Beekhuis WH (2000) A quick surgical technique for deep, anterior lamellar keratoplasty using visco-dissection. Cornea 19:427–432

    Article  PubMed  CAS  Google Scholar 

  35. Anwar M, Teichmann KD (2002) Big-bubble technique to bare Descemet’s membrane in anterior lamellar keratoplasty. J Cataract Refract Surg 28:398–403

    Article  PubMed  Google Scholar 

  36. Anwar M, Teichmann KD (2002) Deep lamellar keratoplasty: surgical techniques for anterior lamellar keratoplasty with and without baring of Descemet’s membrane. Cornea 21:374–383

    Article  PubMed  Google Scholar 

  37. Fogla R, Padmanabhan P (2006) Results of deep lamellar keratoplasty using the big-bubble technique in patients with keratoconus. Am J Ophthalmol 141:254–259

    Article  PubMed  Google Scholar 

  38. Melles GR, Eggink FA, Lander F et al (1998) A surgical technique for posterior lamellar keratoplasty. Cornea 17:618–626

    Article  PubMed  CAS  Google Scholar 

  39. Melles GR, Lander F, Beekhuis WH et al (1999) Posterior lamellar keratoplasty for a case of pseudophakic bullous keratopathy. Am J Ophthalmol 127:340–341

    Article  PubMed  CAS  Google Scholar 

  40. Melles GR, Wijdh RH, Nieuwendaal CP (2004) A technique to excise the Descemet membrane from a recipient cornea (descemetorhexis). Cornea 23:286–288

    Article  PubMed  Google Scholar 

  41. Melles GR, Lander F, Nieuwendaal C (2002) Sutureless, posterior lamellar keratoplasty: a case report of a modified technique. Cornea 21:325–327

    Article  PubMed  Google Scholar 

  42. Price MO, Price FW Jr (2006) Descemet’s stripping with endothelial keratoplasty comparative outcomes with microkeratome-dissected and manually dissected donor tissue. Ophthalmology 24:24

    Google Scholar 

  43. Price FW Jr, Price MO (2005) Descemet’s stripping with endothelial keratoplasty in 50 eyes: a refractive neutral cornea transplant. J Refract Surg 21:339–345

    PubMed  Google Scholar 

  44. Price FW Jr, Price MO (2006) Descemet’s stripping with endothelial keratoplasty in 200 eyes: early challenges and techniques to enhance donor adherence. J Cataract Refract Surg 32:411–418

    Article  PubMed  Google Scholar 

  45. Terry MA, Ousley PJ (2005) Deep lamellar endothelial keratoplasty visual acuity, astigmatism, and endothelial survival in a large prospective series. Ophthalmology 112:1541–1548

    Article  PubMed  Google Scholar 

  46. Ignacio TS, Nguyen TB, Chuck RS et al (2006) Top hat wound configuration for penetrating keratoplasty using the femtosecond laser: a laboratory model. Cornea 25:336–340

    Article  PubMed  Google Scholar 

  47. Barraquer J (1965) Special methods in corneal surgery. In King H Jr (ed) The cornea world congress. Rutterworths, Washington, DC, pp 586–604

  48. Busin M, Arffa RC (2005) Microkeratome-assisted mushroom keratoplasty with minimal endothelial replacement. Am J Ophthalmol 140:138–140

    Article  PubMed  Google Scholar 

  49. Lindstrom RL, Kaufman HE, Skelnik DL et al (1992) Optisol corneal storage medium. Am J Ophthalmol 114:345–356

    PubMed  CAS  Google Scholar 

  50. Wagoner MD, Gonnah ES (2005) Corneal graft survival after prolonged storage in Optisol-GS. Cornea 24:976–979

    Article  PubMed  Google Scholar 

  51. Hicks CR, Crawford GJ, Lou X et al (2003) Corneal replacement using a synthetic hydrogel cornea, AlphaCor: device, preliminary outcomes and complications. Eye 17:385–392

    Article  PubMed  CAS  Google Scholar 

  52. Zerbe BL, Belin MW, Ciolino JB (2006) Results from the multicenter Boston Type 1 keratoprosthesis study. Ophthalmology 113:1779–1786

    Article  PubMed  Google Scholar 

  53. Tanioka H, Kawasaki S, Yamasaki K et al (2006) Establishment of a cultivated human conjunctival epithelium as an alternative tissue source for autologous corneal epithelial transplantation. Invest Ophthalmol Vis Sci 47:3820–3827

    Article  PubMed  Google Scholar 

  54. Sumide T, Nishida K, Yamato M et al (2006) Functional human corneal endothelial cell sheets harvested from temperature-responsive culture surfaces. FASEB J 20:392–394

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marianne O. Price.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Price, F.W., Price, M.O. Adult keratoplasty: has the prognosis improved in the last 25 years?. Int Ophthalmol 28, 141–146 (2008). https://doi.org/10.1007/s10792-007-9183-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-007-9183-1

Keywords

Navigation